Home › Funds › Vivo Capital, LLC › GERN
Vivo Capital, LLC position in GERN
GERON CORP · Health Care
Vivo Capital, LLC reported holding 8,671,797 shares of GERN (GERON CORP) in its Q2 2026 13F filing — a position valued at US$11.1M, representing 1.01% of its reported portfolio and ranking #28 among its reported holdings. Vivo Capital, LLC has disclosed GERN holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Vivo Capital, LLC's GERN position evolved
Vivo Capital, LLC first disclosed a stake in GERN in Q3 2023 at 16,524,634 shares (US$35.0M). The position peaked in Q3 2024 at 27,225,292 shares, worth US$123.6M. Across 12 filings, Vivo Capital, LLC increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 8 time(s). The most recent filing (Q2 2026) shows 8,671,797 shares valued at US$11.1M. Notable position changes include a 46% increase in Q4 2023 (shares rose 56% over the following quarter), a 68% trim in Q1 2026 (shares fell 14% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 16.52M | $35.03M | New |
| Q4 2023 | 24.14M | $50.94M | Add |
| Q1 2024 | 27.23M | $89.84M | Add |
| Q2 2024 | 27.23M | $115.44M | Hold |
| Q3 2024 | 27.23M | $123.60M | Hold |
| Q4 2024 | 27.23M | $96.38M | Hold |
| Q1 2025 | 27.23M | $43.29M | Hold |
| Q2 2025 | 27.23M | $38.39M | Hold |
| Q3 2025 | 27.23M | $37.30M | Hold |
| Q4 2025 | 27.23M | $35.94M | Hold |
| Q1 2026 | 8.67M | $12.92M | Reduce |
| Q2 2026 | 8.67M | $11.10M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GERN and 13F data
GERN (GERON CORP) is a Health Care company. 18 other funds we track also report a position in GERN — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$54.8M), Soleus Capital Management, L.P. (US$54.8M), Eversept Partners, LP (US$24.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GERN
- RA CAPITAL MANAGEMENT, L.P. 42.81M sh · $54.80M · Q2 2026
- Soleus Capital Management, L.P. 42.81M sh · $54.80M · Q2 2026
- Eversept Partners, LP 18.72M sh · $23.96M · Q2 2026
- Nantahala Capital Management, LLC 12.22M sh · $15.65M · Q2 2026
- Kynam Capital Management, LP 6.84M sh · $8.75M · Q2 2026
More on Vivo Capital, LLC
FAQ
How long has Vivo Capital, LLC held GERN?
Vivo Capital, LLC has disclosed GERN holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Vivo Capital, LLC's current position in GERN?
As of Q2 2026, Vivo Capital, LLC holds 8.67M shares of GERN (GERON CORP), valued at $11.10M, representing 1.01% of its reported portfolio and ranking #28.
Has Vivo Capital, LLC been buying or selling GERN?
In the latest 13F filing (Q2 2026), Vivo Capital, LLC held unchanged its position in GERN. The position peaked in Q3 2024 at 27.23M shares.
Which other funds hold GERN?
Other major institutional holders of GERN include RA CAPITAL MANAGEMENT, L.P., Soleus Capital Management, L.P., Eversept Partners, LP, among 18 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.